Úvodní stránka Aktuální číslo Archiv čísel O časopisu Redakční rada Předplatné Pokyny pro autory Zaslat článek Kontakt English
 
Přihlášení |
 
registrace
   
zapomenuté heslo
 
odeslat
 

Comment to the article N. Dahmardeh et al.
Fingolimod attenuates harmaline-induced passive avoidance memory and motor impairments in a rat model of essential tremor


Comment to the article N. Dahmardeh et al.
Fingolimod attenuates harmaline-induced passive avoidance memory and motor impairments in a rat model of essential tremor

Souhrn


 
předchozí článek  
zobrazit obsah  zobrazit obsah  
 
následující článek
 

I have read, with great interest, the article entitled “Fingolimod attenuates harmaline-induced passive avoidance memory and motor impairments in a rat model of essential tremor”.

In this study, the authors constructed a harmaline-induced tremor model in rats, which has been extensively used as an animal model for essential tremor (ET) [1]. Interestingly, the authors have also found that harmaline can cause cognitive disturdances by using passive avoidance test. Therefore, it is indeed an ideal model to study the effect of fingolimod on cognitive deficits associated with ET. The authors’ results demonstrated that pretreatment with fingolimod could ameliorate harmaline induced tremor, motor dysfunction as well as cognitive impairment, which is exciting. The authors should be congratulated for their laboratory findings on a topic not fully explored.

However, there are two main limitations noted in this article. Although the authors documented that fingolimod was administered (1 mg/kg) intraperitoneally 24 h before harmaline injection, it was not clear how the authors had decided the dosage. Using different doses would better determine the efficacy of fingolimod on ET-associated cognitive deficits. Another issue would be that tremor intensity, motor impairment and passive avoidance memory were evaluated at only one time point (30 min after harmaline injection). It would be of particular interest to know how long the positive effect of fingolimod on harmaline induced tremor and cognitive impairment would last. As shown in other articles, efficacy of specific treatments on harmaline induced tremor was tested at multiple time points [2,3].

Baoqiong Liu, MD, PhD

Department of Internal Medicine

Florida Hospital Medical Center

USA

References

1. Cheng MM, Tang G, Kuo SH. Harmaline-induced tremor in mice: videotape documentation and open questions about the model. Tremor Other Hyperkinet Mov (N Y) 2013; 3: pii. doi: 10.7916/D8H993W3.
2. Shourmasti FR, Goudarzi I, Abrari K et al. Riluzole ameliorates harmaline-induced tremor in rat. Basic Clin Neurosci 2014; 5(2): 138–143.
3. Nahab FB, Handforth A, Brown T et al. Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor. Neurotherapeutics 2012; 9(3): 635–638. doi: 10.1007/s13311-012-0121-1.

Ohodnoťte článek:
 

Celkové hodnocení článku:
 
3/5, hodnoceno 7x
 
 
 

Diskuze čtenářů


Vstoupit do diskuze


Open Journal System
 

Předplatné

Předplaťte si časopis

S předplatným získáváte plný přístup ke všem článkům.

více informací

 

Vědomotní test

 

Aktuální číslo

Vydání číslo: 6 / 2018

zobrazit obsah

 

 

Nejčtenější